Medline Inc. (MDLN) Stock
MDLN has an Alpha Score of 11 out of 100 (poor), computed on Oct 29, 2026 from 3 of 4 sub-scores. 7 of the hedge funds AlphaScala tracks reported MDLN in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Blackstone's at $4.01B. Company insiders reported 0 open-market buys and 9 sales on SEC Form 4 in the 90 days to Nov 3, 2026. Its trailing P/E ratio is 63.8 and its net margin 2.3% (key statistics as of Nov 4, 2026).
What is MDLN's Alpha Score?
How it works →Alpha Score of 11 reflects poor overall profile with poor momentum, poor value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 29, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own MDLN?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Blackstone | 101.79M | $4.01B | -18% |
| Lone Pine Capital Steve Mandel | 20.97M | $826.99M | +78% |
| Viking Global Investors Andreas Halvorsen | 4.84M | $190.93M | -58% |
| Soros Fund Management George Soros (founder) | 1.64M | $64.61M | +27% |
| Millennium Management Israel Englander | 1.07M | $42.05M | -45% |
| Citadel Ken Griffin | 33K | $1.29M | -98% |
| Bridgewater Associates Ray Dalio | 20K | $782.8K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Medline Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 8, 26 | Gic Private Ltd | 10%+ Owner | SELL | 7.82M | $274.8M |
| Oct 6, 26 | Gic Private Ltd | 10%+ Owner | SELL | 2.09M | $73.2M |
| Oct 6, 26 | Gic Private Ltd | 10%+ Owner | SELL | 7.18M | $251.8M |
| Oct 5, 26 | Gic Private Ltd | 10%+ Owner | SELL | 1.69M | $60.4M |
| Oct 2, 26 | Gic Private Ltd | 10%+ Owner | SELL | 2.57M | $90.9M |
| Oct 2, 26 | Gic Private Ltd | 10%+ Owner | SELL | 7.15M | $245.4M |
| Aug 14, 26 | Gic Private Ltd | 10%+ Owner | SELL | 100.0K | $3.6M |
| Aug 13, 26 | Gic Private Ltd | 10%+ Owner | SELL | 1.50M | $53.7M |
| Aug 7, 26 | Gic Private Ltd | 10%+ Owner | SELL | 590.3K | $21.0M |
| Aug 6, 26 | Gic Private Ltd | 10%+ Owner | SELL | 272.0K | $9.6M |
SEC Form 4 filings as of Nov 3, 2026
See cluster-buy signals across all tickers →What are MDLN's key statistics?
Key statistics as of Nov 4, 2026
How does MDLN's valuation compare with the Healthcare sector?
| Metric | MDLN | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 63.8 | 27.0 | 102 |
| Net margin | 2.31% | 4.64% | 150 |
| Return on equity | 5.47% | 6.41% | 169 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 4, 2026). P/E excludes loss-making companies.
MDLN price chart
Powered by TradingViewWhat does Medline Inc. do?
Medline Inc. is a healthcare company specializing in the manufacture, distribution, and management of medical-surgical products and related supply chain solutions. The company serves a broad spectrum of care settings, including hospitals, surgery centers, physician offices, post-acute facilities, and home care providers. Through its Medline Brand and Supply Chain Solutions segments, Medline Inc. offers an extensive portfolio of products such as surgical and procedural kits, personal protective equipment, urological and incontinence care items, wound care products, and consumable laboratory and diagnostic supplies. Leveraging a large-scale logistics network of distribution centers and dedicated transportation assets, it focuses on reliable, next-day delivery and integrated supply chain services for healthcare providers. Founded in 1966 and headquartered in Northfield, Illinois, Medline Inc. has grown into a leading player in the medical instruments and supplies industry, supporting clinical efficiency and operational resiliency across the healthcare continuum.